Skip to main content

Indira IVF IPO: Did Tumko Meri Kasam derail the Rs 3,500 crores plan? March 26, 2025 at 02:30PM

The intersection of Bollywood and business took an unexpected turn in 2025 when a movie reportedly disrupted Indira IVF’s much-anticipated Rs 3,500 crores initial public offering (IPO). The EQT-backed fertility clinic chain, a leader in India’s growing IVF sector, faced regulatory hurdles from the Securities and Exchange Board of India (SEBI) over the release of Tumko Meri Kasam. This Bollywood biopic, centred on Indira IVF founder Ajay Murdia, has sparked debates about the influence of media on financial markets, as per a report by Economic Times. Here’s a deep dive into how this unforeseen twist unfolded and its implications for Indira IVF’s IPO plans.

The Rise of Indira IVF: A Leader in Fertility Treatments Founded in 2011 by Ajay Murdia in Udaipur, Indira IVF has grown into one of India’s most prominent fertility clinic chains. With over 150 centres and 330 specialists nationwide, the company has capitalized on the increasing demand for in-vitro fertilization (IVF) treatments. Backed by private equity giant EQT, which acquired a controlling stake in 2023 from TA Associates and the Murdia family, Indira IVF aimed to raise Rs 3,500 crores through its IPO to fuel further expansion. The IPO was poised to be one of the largest healthcare listings of 2025—until an unexpected roadblock emerged. Tumko Meri Kasam: A Bollywood Biopic with Big Implications Directed by Vikram Bhatt and starring Anupam Kher and Esha Deol, Tumko Meri Kasam hit theatres just days before the IPO filing. The nearly three-hour film, made on a modest Rs 12 crores budget, portrays the journey of Ajay Murdia and the rise of Indira IVF. Featuring dramatic courtroom scenes, special effects, and a soundtrack with songs like ‘Ishqaa Ishqaa’ and ‘Zara Paas Aana,’ the movie aimed to entertain. However, its box office performance was lacklustre.

While critics panned the film, SEBI’s concerns were far more serious. The regulator flagged the movie’s release as a potential violation of disclosure norms and fair market practices. SEBI suspected that Tumko Meri Kasam could serve as indirect promotional material, influencing investor sentiment ahead of the IPO. This led to the withdrawal of Indira IVF’s draft red herring prospectus (DRHP), halting what could have been a landmark listing. SEBI’s Role: Protecting Investors or Stifling Innovation? SEBI’s objection highlights its stringent oversight of IPO-bound companies. The regulator’s rules aim to ensure transparency and prevent companies from manipulating public perception before going public. In this case, the timing of the movie’s release—just weeks after Indira IVF filed its DRHP via the confidential pre-filing route—raised red flags. It is speculated that SEBI feared the biopic could artificially inflate interest in the IPO, prompting the company to pull back its plans temporarily.

While SEBI and Indira IVF did not officially comment, insiders claim the withdrawal was also influenced by unfavourable market conditions. The company intends to refile its IPO papers once the primary market stabilizes. What’s Next for Indira IVF’s IPO? With its IPO shelved for now, Indira IVF faces a critical juncture. The company could refile with SEBI once market conditions improve and regulatory concerns are addressed. Alternatively, it might explore private funding options to sustain growth. The Rs 3,500 crores IPO was meant to solidify Indira IVF’s position in India’s booming healthcare sector.

Also Read: Esha Deol on her theatrical comeback with Tumko Meri Kasam, “I would say it’s homecoming”



from Latest Bollywood News | Hindi Movie News | Hindi Cinema News | Indian Movies | Films - Bollywood Hungama https://ift.tt/d1ZGtnQ

Comments

Popular posts from this blog

Makers of Rajkummar Rao-Janhvi Kapoor’s Mr And Mrs Mahi recreate a portion of Kabhi Khushi Kabhie Gham’s song ‘Say Shava Shava’? May 08, 2024 at 01:36PM

The dry period in Bollywood might temporarily halt with the release of this week’s Srikanth, starring Rajkummar Rao, Jyotika, Alaya F and Sharad Kelkar. The movie-watching season will begin in full force with Mr And Mrs Mahi, which will arrive in cinemas on May 31. Bollywood Hungama reported last week that the trailer is on its way. Now, we bring to you another interesting development about this film, starring Rajkummar Rao and Janhvi Kapoor. A source told us, “The makers of the film have recreated the much-loved song ‘Say Shava Shava’ from Kabhi Khushi Kabhie Gham (2001) for this film. The recreation is not done for the whole song. Rather, they have only chosen to recreate the stanza that begins with the line ‘Dekho Tainu Pehli Pehli Baar Ve’. It’s played during an important scene between the lead actors, Rajkummar and Janhvi.” Interestingly, Kabhi Khushi Kabhie Gham was directed b...

Shahid Kapoor, Anees Bazmee and Rashmika Mandanna's next with Dil Raju to start from August 1 May 18, 2023 at 11:00AM

After working in the industry for 20 years, Shahid Kapoor is finally gearing up for his first film with ace filmmaker, Anees Bazmee. The actor will be seen in a double role in this out and out comic commercial entertainer, produced by Dil Raju.  The film will feature Rashmika Mandanna in female lead and is among the awaited films from Shahid Kapoor's line up. Bollywood Hungama has got to know that Shahid Kapoor has allotted his dates to Anees Bazmee and will soon commence shooting for this comic caper. According to our sources close to the development, Shahid Kapoor will start shooting for Anees Bazmee's comedy from August 1. "Shahid Kapoor is very excited to do an out and out comedy after a long time and will commence his work on the film from August 1. He has allotted bulk dates to Anees Bazmee from August to December as the team is planning a start to finish schedule," revealed a trade source to Bollywood Hungama. Shahid will have two distinct looks in the film a...

Bombay High Court orders stays the release of Hamare Baarah, two days before the film’s release June 07, 2024 at 01:02PM

Hamare Baarah, which is making news for its bold approach and thought-provoking plotline, has been mired in controversy, with the makers landing in deep trouble. The highly anticipated release of Annu Kapoor, Manoj Joshi, and Paritosh Tripathi starrer, has encountered a significant setback as the Bombay High Court has issued a stay on its release just two days before its scheduled release on June 7, extending the hold until June 14. This unexpected turn of events has impacted the premiere of the film which was expected to be held this week, leaving makers in an uncertain dilemma. The legal obstacle arises from a petition filed by activists from a specific religious community at the Mumbai High Court, opposing the film's release. Producers Birender Bhagat and Ravi S Gupta have raised serious concerns regarding the imposition of the stay, especially given that the film had already obtained a censor certificate. In a recent statement given to NDTV, Mr Bhagat explained their predicame...